Sagimet Biosciences
Stock Forecast, Prediction & Price Target

Sagimet Biosciences Financial Estimates

Sagimet Biosciences Revenue Estimates

Sagimet Biosciences EBITDA Estimates

Sagimet Biosciences Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$2M
 
0%
Avg: $2M
Low: $2M
High: $2M
avg. 0%
Avg: $2M
Low: $2M
High: $2M
avg. 0%
Net Income
 
% change YoY
$-24.44M
 
N/A
$-30.49M
 
-24.78%
$-27.87M
 
8.60%
Avg: $-116.40M
Low: $-120.21M
High: $-43.21M
avg. -317.59%
Avg: $-181.28M
Low: $-144.77M
High: $-78.40M
avg. -55.73%
EBITDA
 
% change YoY
$-23.71M
 
N/A
$-31.05M
 
-30.92%
$-30.74M
 
1.01%
Avg: $1.2M
Low: $1.2M
High: $1.2M
avg. 103.90%
Avg: $1.2M
Low: $1.2M
High: $1.2M
avg. 0%
EPS
 
% change YoY
-$1.1
 
N/A
-$1.38
 
-25.45%
-$2.66
 
-92.75%
Avg: -$3.68
Low: -$5.09
High: -$1.83
avg. -38.15%
Avg: -$5.01
Low: -$6.13
High: -$3.32
avg. -36.19%
Operating Expenses
 
% change YoY
$23.71M
 
N/A
$31.05M
 
30.92%
$32.74M
 
5.42%
Avg: $4.19M
Low: $4.19M
High: $4.19M
avg. -87.19%
Avg: $4.19M
Low: $4.19M
High: $4.19M
avg. 0%

FAQ

What is Sagimet Biosciences stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -186.66% in 2025-2026.

We have gathered data from 4 analysts. Their low estimate is -120.21M, average is -116.40M and high is -43.21M.

What is Sagimet Biosciences stock revenue growth forecast?

We have gathered data from 4 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.

What is Sagimet Biosciences stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -37.17% in 2025-2026.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$5.09, average is -$3.68 and high is $-1.83.

What is the best performing analyst?

In the last twelve months analysts have been covering Sagimet Biosciences stock. The most successful analyst is Andrea Tan.